Gonadoblastoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
Line 14: | Line 14: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] |
Latest revision as of 21:54, 29 July 2020
Gonadoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gonadoblastoma secondary prevention On the Web |
American Roentgen Ray Society Images of Gonadoblastoma secondary prevention |
Risk calculators and risk factors for Gonadoblastoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
There are no established measures for the secondary prevention of gonadoblastoma.
Secondary Prevention
There are no established measures for the secondary prevention of gonadoblastoma.